These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 21478743)
1. Ideal lipid profile and genes for an extended life span. Kolovou G; Kolovou V; Vasiliadis I; Wierzbicki AS; Mikhailidis DP Curr Opin Cardiol; 2011 Jul; 26(4):348-55. PubMed ID: 21478743 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
3. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents. Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967 [TBL] [Abstract][Full Text] [Related]
4. Achieving vascular risk factor targets: a survey of a London general practice. Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M Angiology; 2008; 59(1):36-46. PubMed ID: 18319220 [TBL] [Abstract][Full Text] [Related]
5. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. Ong HT QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501 [TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Fabbri G; Maggioni AP Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394 [TBL] [Abstract][Full Text] [Related]
9. A prospective study of pravastatin in the elderly at risk: new hope for older persons. Shepherd J Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):17-24. PubMed ID: 15133425 [TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J; Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264 [TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia as a risk factor at elderly age. Wenger NK Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):4-9. PubMed ID: 15133423 [TBL] [Abstract][Full Text] [Related]
13. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. Hague W; Forder P; Simes J; Hunt D; Tonkin A; Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760 [TBL] [Abstract][Full Text] [Related]
14. Statins for stroke prevention: disappointment and hope. Amarenco P; Tonkin AM Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966 [TBL] [Abstract][Full Text] [Related]
15. [Does statin therapy reduce the risk of stroke? A meta-analysis]. Sirol M; Bouzamondo A; Sanchez P; Lechat P Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579 [TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
18. The future of lipid-lowering therapy: the big picture. Kastelein JJ Neth J Med; 2003 May; 61(5 Suppl):35-9. PubMed ID: 12918548 [TBL] [Abstract][Full Text] [Related]
19. Initiating statins in the elderly: the evolving challenge. Walker DB; Jacobson TA Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):182-7. PubMed ID: 18316955 [TBL] [Abstract][Full Text] [Related]